Luca Issi Analyst PerformanceSenior Biotechnology Analyst at Royal Bank Of CanadaLuca Issi is a stock analyst at Royal Bank Of Canada focused in the medical sector, covering 29 publicly traded companies. Over the past year, Luca Issi has issued 51 stock ratings, including buy and hold recommendations. While full access to Luca Issi's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Luca Issi's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings80 Last 1 YearsBuy Recommendations61.25% 49 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution80RatingsDistribution of strong buy, buy, hold, and sell ratings by Luca Issi.RatingPercentageCount Strong Buy0.0%0 ratings Buy61.3%49 ratings Hold38.8%31 ratings Sell0.0%0 ratingsOut of 80 total stock ratings issued by Luca Issi at Royal Bank Of Canada, the majority (61.3%) have been Buy recommendations, followed by 38.8% Hold.Best & Worst CallsBest Call0000.0%ARWRFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%KRROMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.6% of companies on NASDAQ28 companiesNYSE3.4% of companies on NYSE1 companyLuca Issi, an analyst at Royal Bank Of Canada, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical28 companies96.6%Energy1 company3.4%Luca Issi of Royal Bank Of Canada specializes in stock coverage within the Medical sector, with additional focus on Energy companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE20 companies69.0%MED - DRUGS7 companies24.1%MED - GENERIC DRG1 company3.4%OIL - FIELD SVCS1 company3.4% Luca Issi's Ratings History at Royal Bank Of Canada Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsARWRArrowhead Pharmaceuticals5/8/2026Boost Price Target$74.04$87.00Outperform$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/5/2026Reiterated Rating$54.43$66.00Sector Perform$0.0000.00% ROIMRNAModerna5/4/2026Boost Price Target$46.82$38.00Sector Perform$0.0000.00% ROIALNYAlnylam Pharmaceuticals5/1/2026Lower Price Target$300.78$445.00Outperform$0.0000.00% ROIIONSIonis Pharmaceuticals4/30/2026Boost Price Target$74.76$100.00Outperform$0.0000.00% ROIBBIOBridgeBio Pharma4/9/2026Initiated Coverage$74.14$100.00Outperform$0.0000.00% ROIBBIOBridgeBio Pharma4/8/2026Upgrade$75.52Moderate Buy$0.0000.00% ROIQUREuniQure3/9/2026Upgrade$14.27$35.00Outperform$0.0000.00% ROINTLAIntellia Therapeutics3/3/2026Boost Price Target$14.00$15.00Sector Perform$0.0000.00% ROIASNDAscendis Pharma A/S3/2/2026Boost Price Target$242.09$275.00Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. QUREuniQure3/2/2026Downgrade$10.37$11.00Sector Perform$0.0000.00% ROIARGXargenex2/27/2026Lower Price Target$773.97$890.00Outperform$0.0000.00% ROIQUREuniQure2/26/2026Reiterated Rating$17.11$11.00Sector Perform$0.0000.00% ROIIONSIonis Pharmaceuticals2/25/2026Reiterated Rating$81.09Outperform$0.0000.00% ROIBEAMBeam Therapeutics2/25/2026Boost Price Target$32.40$26.00Sector Perform$0.0000.00% ROIMRNAModerna2/17/2026Boost Price Target$43.20$30.00Sector Perform$0.0000.00% ROIASNDAscendis Pharma A/S1/20/2026Boost Price Target$205.83$250.00Outperform$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/20/2026Lower Price Target$349.07$465.00Outperform$0.0000.00% ROIMRNAModerna1/12/2026Reiterated Rating$33.85Sector Perform$0.0000.00% ROIIONSIonis Pharmaceuticals12/17/2025Boost Price Target$78.37$95.00Outperform$0.0000.00% ROIARGXargenex12/17/2025Boost Price Target$861.66$925.00Outperform$0.0000.00% ROIARWRArrowhead Pharmaceuticals12/11/2025Boost Price Target$70.05$80.00Outperform$0.0000.00% ROIWVEWAVE Life Sciences12/8/2025Upgrade$18.52$27.00Outperform$0.0000.00% ROIFULCFulcrum Therapeutics12/8/2025Boost Price Target$8.90$10.00Sector Perform$0.0000.00% ROIMRNAModerna11/21/2025Lower Price Target$22.90$25.00Sector Perform$0.0000.00% ROIARWRArrowhead Pharmaceuticals11/19/2025Boost Price Target$40.85$52.00Outperform$0.0000.00% ROIAGIOAgios Pharmaceuticals11/19/2025Downgrade$22.69$28.00Sector Perform$0.0000.00% ROIKRROKorro Bio11/13/2025Downgrade$31.42Sector Perform$0.0000.00% ROICRSPCRISPR Therapeutics11/11/2025Boost Price Target$54.58$50.00Sector Perform$0.0000.00% ROINTLAIntellia Therapeutics11/7/2025Lower Price Target$9.19$9.00Sector Perform$0.0000.00% ROIRGNXREGENXBIO11/7/2025Boost Price Target$11.27$19.00Outperform$0.0000.00% ROIDYNDyne Therapeutics11/6/2025Boost Price Target$17.87$30.00Outperform$0.0000.00% ROIQUREuniQure11/3/2025Lower Price Target$34.29$45.00Outperform$0.0000.00% ROIARGXargenex10/31/2025Boost Price Target$816.27$860.00Outperform$0.0000.00% ROIFULCFulcrum Therapeutics10/30/2025Boost Price Target$9.29$7.00Sector Perform$0.0000.00% ROIIONSIonis Pharmaceuticals10/30/2025Boost Price Target$73.96$82.00Outperform$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/28/2025Reiterated Rating$53.68$66.00Sector Perform$0.0000.00% ROINTLAIntellia Therapeutics10/28/2025Reiterated Rating$14.79$14.00Sector Perform$0.0000.00% ROIRNAAvidity Biosciences10/28/2025Reiterated Rating$70.00$72.00Sector Perform$0.0000.00% ROINTLAIntellia Therapeutics10/28/2025Downgrade$13.96$14.00Sector Perform$0.0000.00% ROIA 17-year investing experiment investigated in Dublin (Ad)Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.Watch the full investigation and decide for yourselfRNAAvidity Biosciences10/28/2025Downgrade$69.93$72.00Sector Perform$0.0000.00% ROIALNYAlnylam Pharmaceuticals9/19/2025Boost Price Target$452.17$500.00Outperform$0.0000.00% ROIIONSIonis Pharmaceuticals9/4/2025Boost Price Target$60.56$80.00Outperform$0.0000.00% ROIARGXargenex8/25/2025Initiated Coverage$660.00$850.00Outperform$0.0000.00% ROINTLAIntellia Therapeutics8/8/2025Lower Price Target$10.72$21.00Outperform$0.0000.00% ROIASNDAscendis Pharma A/S8/8/2025Boost Price Target$190.21$230.00Outperform$0.0000.00% ROIARWRArrowhead Pharmaceuticals8/8/2025Lower Price Target$16.10$38.00Outperform$0.0000.00% ROIRGNXREGENXBIO8/8/2025Lower Price Target$7.82$17.00Outperform$0.0000.00% ROICRSPCRISPR Therapeutics8/5/2025Boost Price Target$53.14$42.00Sector Perform$0.0000.00% ROIFULCFulcrum Therapeutics7/30/2025Boost Price Target$6.96$5.00Sector Perform$0.0000.00% ROIDYNDyne Therapeutics7/29/2025Lower Price Target$8.94$23.00Outperform$0.0000.00% ROIADVMAdverum Biotechnologies5/15/2025Lower Price Target$1.91$4.00Sector Perform$0.0000.00% ROIALLOAllogene Therapeutics5/14/2025Reiterated Rating$0.90$10.00Outperform$0.0000.00% ROIAPLSApellis Pharmaceuticals5/8/2025Lower Price Target$18.14$18.00Sector Perform$00.0000.00% ROIMRNAModerna5/2/2025Lower Price Target$27.54$28.00Sector Perform$00.0000.00% ROIASNDAscendis Pharma A/S4/16/2025Initiated Coverage$153.92$205.00Outperform$000.0000.00% ROIADVMAdverum Biotechnologies4/16/2025Lower Price Target$3.20$5.00Sector Perform$0.0000.00% ROILXEOLexeo Therapeutics3/25/2025Lower Price Target$3.88$20.00Outperform$0.0000.00% ROIALNYAlnylam Pharmaceuticals3/21/2025Boost Price Target$281.35$330.00Outperform$000.0000.00% ROIKRROKorro Bio3/19/2025Lower Price Target$24.13$95.00Outperform$00.0000.00% ROIOCULOcular Therapeutix3/18/2025Initiated Coverage$7.94$17.00Outperform$0.0000.00% ROISGMOSangamo Therapeutics3/18/2025Reiterated Rating$0.86$2.00Sector Perform$0.0000.00% ROIMGTXMeiraGTx3/17/2025Boost Price Target$7.77$13.00Outperform$0.0000.00% ROIALLOAllogene Therapeutics3/14/2025Reiterated Rating$1.90$10.00Outperform$0.0000.00% ROIVERVVerve Therapeutics3/4/2025Lower Price Target$5.75$15.00Outperform$0.0000.00% ROIFDMT4D Molecular Therapeutics3/3/2025Lower Price Target$4.47$35.00Outperform$0.0000.00% ROIALNYAlnylam Pharmaceuticals2/26/2025Reiterated Rating$249.62$310.00Outperform$000.0000.00% ROIBEAMBeam Therapeutics2/26/2025Boost Price Target$28.85$26.00Sector Perform$00.0000.00% ROIBMRNBioMarin Pharmaceutical2/20/2025Reiterated Rating$68.99$70.00Sector Perform$00.0000.00% ROIIONSIonis Pharmaceuticals2/20/2025Reiterated Rating$32.26$70.00Outperform$00.0000.00% ROIMRNAModerna2/18/2025Reiterated Rating$35.72$40.00Sector Perform$00.0000.00% ROICRSPCRISPR Therapeutics2/12/2025Lower Price Target$42.75$48.00Sector Perform$00.0000.00% ROIARWRArrowhead Pharmaceuticals2/11/2025Reiterated Rating$18.56$42.00Outperform$00.0000.00% ROIALNYAlnylam Pharmaceuticals2/11/2025Reiterated Rating$269.35$300.00Outperform$000.0000.00% ROIRGNXREGENXBIO1/21/2025Reiterated Rating$7.39$30.00Outperform$00.0000.00% ROILXEOLexeo Therapeutics1/21/2025Reiterated Rating$4.93$24.00Outperform$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/21/2025Reiterated Rating$257.98$300.00Outperform$000.0000.00% ROIQUREuniQure1/21/2025Reiterated Rating$14.50$24.00Outperform$00.0000.00% ROISLBSLB1/21/2025Reiterated Rating$44.09$57.00Outperform$00.0000.00% ROIIONSIonis Pharmaceuticals1/15/2025Reiterated Rating$33.69$70.00Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
